$dgly the best call I have ever heard from this company 50 million quarter 1 of 2022 40 million cash on hand. Rissehouse innocent options expire the 19th see you all above 10$
$BIOR Biora is developing the PGN-600 program, which consists of a liquid formulation of tofacitinib delivered to the colon via the DDS capsule, for the treatment of ulcerative colitis.